EMEA-001720-PIP01-14-M02
Key facts
| Invented name |
Veltassa
|
| Active substance |
Patiromer calcium
|
| Therapeutic area |
Other
|
| Decision number |
P/0367/2021
|
| PIP number |
EMEA-001720-PIP01-14-M02
|
| Pharmaceutical form(s) |
Powder for oral suspension
|
| Condition(s) / indication(s) |
Treatment of hyperkalaemia
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Vifor Fresenius Medical Care Renal Pharma France
Tel. +41 5885 18275 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|